Adaptive Biotechnologies Corporation
ADPT
$15.80
-$0.32-1.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 62.69% | 59.30% | 43.21% | 34.05% | 29.19% |
| Total Depreciation and Amortization | -7.39% | -10.47% | -14.50% | -14.75% | -13.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.45% | -40.62% | -41.70% | -31.85% | -32.73% |
| Change in Net Operating Assets | -230.97% | -117.59% | -6.02% | 27.25% | 62.21% |
| Cash from Operations | 51.70% | 44.80% | 37.75% | 37.03% | 39.09% |
| Capital Expenditure | 19.24% | 50.78% | 68.04% | 63.25% | 65.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.78% | 10.92% | -32.61% | -48.31% | -41.96% |
| Cash from Investing | -51.22% | 16.03% | -29.36% | -47.06% | -40.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12,515.35% | 4,313.93% | 3,960.67% | 249.29% | -89.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12,515.35% | 4,313.93% | 3,960.67% | 249.29% | -89.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.20% | 132.95% | 65.73% | 8.32% | 29.69% |